Denali Therapeutics Inc. DNLI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 516.20M | 710.47M | 987.68M | 867.88M | 848.20M |
| Total Receivables | 18.88M | 5.43M | 1.60M | 2.18M | 1.90M |
| Inventory | 26.28M | 4.14M | -- | -- | -- |
| Prepaid Expenses | 30.36M | 33.89M | 33.47M | 30.60M | 32.49M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 591.71M | 753.93M | 1.02B | 900.66M | 882.60M |
|
|
|||||
| Total Current Assets | 591.71M | 753.93M | 1.02B | 900.66M | 882.60M |
| Net Property, Plant & Equipment | 109.30M | 113.42M | 117.27M | 119.94M | 123.21M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 34.50M | 35.25M | 36.00M | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.15M | 10.83M | 11.22M | 10.94M | 10.11M |
| Total Assets | 1.26B | 1.16B | 1.27B | 1.14B | 1.06B |
|
|
|||||
| Total Accounts Payable | 13.70M | 11.81M | 40.38M | 3.33M | 6.75M |
| Total Accrued Expenses | 54.63M | 48.12M | 44.80M | 64.37M | 51.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.51M | 10.18M | 9.86M | 9.55M | 9.24M |
| Total Finance Division Other Current Liabilities | 16.42M | 19.98M | 15.12M | 21.10M | 22.58M |
| Total Other Current Liabilities | 16.42M | 19.98M | 15.12M | 21.10M | 22.58M |
| Total Current Liabilities | 95.26M | 90.08M | 110.16M | 98.35M | 90.15M |
|
|
|||||
| Total Current Liabilities | 95.26M | 90.08M | 110.16M | 98.35M | 90.15M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 24.73M | 27.51M | 30.19M | 32.74M | 35.24M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 209.66M | 205.19M | 199.58M | -- | 4.04M |
| Total Liabilities | 329.65M | 322.78M | 339.93M | 131.09M | 129.42M |
|
|
|||||
| Common Stock & APIC | 3.17B | 3.14B | 3.11B | 3.06B | 2.85B |
| Retained Earnings | -2.24B | -2.31B | -2.18B | -2.05B | -1.92B |
| Treasury Stock & Other | -6.36M | -1.97M | -682.00K | 682.00K | 1.10M |
| Total Common Equity | 926.39M | 835.18M | 926.10M | 1.01B | 926.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 926.39M | 835.18M | 926.10M | 1.01B | 926.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 926.39M | 835.18M | 926.10M | 1.01B | 926.20M |
|
|
|||||